国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
International Medicine and Health Guidance News
2015年
19期
2844-2846
,共3页
泌尿生殖道萎缩%阴道雌激素%盆底康复%联合%绝经后女性
泌尿生殖道萎縮%陰道雌激素%盆底康複%聯閤%絕經後女性
비뇨생식도위축%음도자격소%분저강복%연합%절경후녀성
Urogenital atrophy%Vaginal estrogen%Pelvic floor rehabilitation%Combination%Postmenopausal women
目的 探讨阴道雌激素联合盆底康复对绝经后女性泌尿生殖道萎缩的治疗效果.方法 选取2014年2月至2015年2月于我院接收治疗的197例泌尿道萎缩绝经后女性,以随机分组法分为观察组与对照组,对照组患者采用普罗雌烯乳膏行阴道涂抹治疗,1g/次,1次/d,症状好转后用药改为2次/周,1g/次,治疗周期为2个月;观察组在对照组基础上,加以联合盆底康复治疗法,治疗周期为2个月.比较两组治疗效果.结果 两组患者阴道萎缩症状有明显好转,前后比较,差异有统计学意义(P<0.01);观察组患者尿失禁、阴道干涩、性交困难、菌尿阳性各顶指标好转情况均优于对照组,差异有统计学意义(P< 0.01).结论 阴道雌激素联合盆底康复对绝经后女性泌尿生殖道萎缩具有良好的治疗效果,具有临床推广价值.
目的 探討陰道雌激素聯閤盆底康複對絕經後女性泌尿生殖道萎縮的治療效果.方法 選取2014年2月至2015年2月于我院接收治療的197例泌尿道萎縮絕經後女性,以隨機分組法分為觀察組與對照組,對照組患者採用普囉雌烯乳膏行陰道塗抹治療,1g/次,1次/d,癥狀好轉後用藥改為2次/週,1g/次,治療週期為2箇月;觀察組在對照組基礎上,加以聯閤盆底康複治療法,治療週期為2箇月.比較兩組治療效果.結果 兩組患者陰道萎縮癥狀有明顯好轉,前後比較,差異有統計學意義(P<0.01);觀察組患者尿失禁、陰道榦澀、性交睏難、菌尿暘性各頂指標好轉情況均優于對照組,差異有統計學意義(P< 0.01).結論 陰道雌激素聯閤盆底康複對絕經後女性泌尿生殖道萎縮具有良好的治療效果,具有臨床推廣價值.
목적 탐토음도자격소연합분저강복대절경후녀성비뇨생식도위축적치료효과.방법 선취2014년2월지2015년2월우아원접수치료적197례비뇨도위축절경후녀성,이수궤분조법분위관찰조여대조조,대조조환자채용보라자희유고행음도도말치료,1g/차,1차/d,증상호전후용약개위2차/주,1g/차,치료주기위2개월;관찰조재대조조기출상,가이연합분저강복치요법,치료주기위2개월.비교량조치료효과.결과 량조환자음도위축증상유명현호전,전후비교,차이유통계학의의(P<0.01);관찰조환자뇨실금、음도간삽、성교곤난、균뇨양성각정지표호전정황균우우대조조,차이유통계학의의(P< 0.01).결론 음도자격소연합분저강복대절경후녀성비뇨생식도위축구유량호적치료효과,구유림상추엄개치.
Objective To investigate the treatment effect of vaginal estrogen in the combination of pelvic floor rehabilitation for urogenital atrophy in postmenopausal women.Methods 197 postmenopausal women with urogenital atrophy treated at our hospital from February, 2014 to February, 2015 were selected and were randomly divided into an observation group and a control group.The control group were vaginally smeared with promestriene cream, 1 g: 0.01 g, 1 g once, once a day;when the symptoms were improved,promestriene cream was used twice a week, 1 g once, for 2 months.In addition, the observation group were treated with pelvic floor rehabilitation therapy for 2 months.The treatment effect were compared between these two groups.Results The symptoms of vaginal atrophy were much better after than before the treatment in both groups, with statistical differences (P<0.01).Urinary incontinence, vaginal dryness,dyspareunia, bacteriuria positiveness etc.were improve much more in the observation group than in the control group, with statistical differences (P<0.01).Conclusions Vaginal estrogen in the combination of pelvic floor rehabilitation for urogenital atrophy in postmenopausal women is effective and worth being clinically generalized.
